{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:26:47Z","timestamp":1774538807483,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T00:00:00Z","timestamp":1771286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T00:00:00Z","timestamp":1774483200000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-026-09721-9","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T14:15:09Z","timestamp":1771337709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CD25 modulation enhances broadly neutralizing antibody response of SARS-CoV-2 subunit vaccine"],"prefix":"10.1038","volume":"9","author":[{"given":"Fangshen","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunhe","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenmo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haochen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2454-7652","authenticated-orcid":false,"given":"Pengfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3533-4049","authenticated-orcid":false,"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7739-1386","authenticated-orcid":false,"given":"Xianghui","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,17]]},"reference":[{"key":"9721_CR1","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1056\/NEJMra2206573","volume":"387","author":"DH Barouch","year":"2022","unstructured":"Barouch, D. H. Covid-19 vaccines - immunity, variants, boosters. N. Engl. J. Med. 387, 1011\u20131020 (2022).","journal-title":"N. Engl. J. Med."},{"key":"9721_CR2","doi-asserted-by":"publisher","first-page":"2969","DOI":"10.1002\/jmv.27697","volume":"94","author":"S Chenchula","year":"2022","unstructured":"Chenchula, S., Karunakaran, P., Sharma, S. & Chavan, M. Current evidence on efficacy of COVID-19 booster dose vaccination against the Omicron variant: a systematic review. J. Med. Virol. 94, 2969\u20132976 (2022).","journal-title":"J. Med. Virol."},{"key":"9721_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-021-00657-1","volume":"22","author":"BJ Laidlaw","year":"2022","unstructured":"Laidlaw, B. J. & Ellebedy, A. H. The germinal centre B cell response to SARS-CoV-2. Nat. Rev. Immunol. 22, 7\u201318 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"9721_CR4","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1016\/j.immuni.2020.11.009","volume":"53","author":"K Lederer","year":"2020","unstructured":"Lederer, K. et al. SARS-CoV-2 mRNA vaccines foster potent antigen-specific germinal center responses associated with neutralizing antibody generation. Immunity 53, 1281 (2020).","journal-title":"Immunity"},{"key":"9721_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2023.102308","volume":"82","author":"X Liu","year":"2023","unstructured":"Liu, X., Liu, B. & Qi, H. Germinal center reaction and output: recent advances. Curr. Opin. Immunol. 82, 102308 (2023).","journal-title":"Curr. Opin. Immunol."},{"key":"9721_CR6","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1126\/science.abn8934","volume":"379","author":"A Aung","year":"2023","unstructured":"Aung, A. et al. Low protease activity in B cell follicles promotes retention of intact antigens after immunization. Science 379, 350\u201335 (2023).","journal-title":"Science"},{"key":"9721_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.copbio.2018.01.006","volume":"51","author":"PA Robert","year":"2018","unstructured":"Robert, P. A., Marschall, A. L. J. & Meyer-Hermann, M. Induction of broadly neutralizing antibodies in Germinal Centre simulations. Curr. Opin. Biotechnol. 51, 137\u2013145 (2018).","journal-title":"Curr. Opin. Biotechnol."},{"key":"9721_CR8","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/s41586-022-05216-9","volume":"609","author":"JH Lee","year":"2022","unstructured":"Lee, J. H. et al. Long-primed germinal centres with enduring affinity maturation and clonal migration. Nature 609, 998 (2022).","journal-title":"Nature"},{"key":"9721_CR9","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.cell.2019.04.012","volume":"177","author":"KM Cirelli","year":"2019","unstructured":"Cirelli, K. M. et al. Slow delivery immunization enhances HIV neutralizing antibody and germinal center responses via modulation of immunodominance. Cell 177, 1153 (2019).","journal-title":"Cell"},{"key":"9721_CR10","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.3389\/fimmu.2018.01910","volume":"9","author":"JB Wing","year":"2018","unstructured":"Wing, J. B., Tekg\u00fc\u00e7, M. & Sakaguchi, S. Control of germinal center responses by T-follicular regulatory cells. Front. Immunol. 9, 1910 (2018).","journal-title":"Front. Immunol."},{"key":"9721_CR11","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1186\/s13075-014-0471-7","volume":"16","author":"I Vanderleyden","year":"2014","unstructured":"Vanderleyden, I., Linterman, M. A. & Smith, K. G. C. Regulatory T cells and control of the germinal centre response. Arthritis Res. Ther. 16, 471 (2014).","journal-title":"Arthritis Res. Ther."},{"key":"9721_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14670-w","volume":"11","author":"T Bradley","year":"2020","unstructured":"Bradley, T. et al. Immune checkpoint modulation enhances HIV-1 antibody induction. Nat. Commun. 11, 948 (2020).","journal-title":"Nat. Commun."},{"key":"9721_CR13","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1002\/ijc.34281","volume":"152","author":"YJ Peng","year":"2023","unstructured":"Peng, Y. J. et al. CD25: a potential tumor therapeutic target. Int. J. Cancer 152, 1290\u20131303 (2023).","journal-title":"Int. J. Cancer"},{"key":"9721_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-02449-y","volume":"11","author":"DY Song","year":"2021","unstructured":"Song, D. Y. et al. Two novel human anti-CD25 antibodies with antitumor activity inversely related to their affinity and in vitro activity. Sci. Rep. 11, 22966 (2021).","journal-title":"Sci. Rep."},{"key":"9721_CR15","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1158\/1538-7445.AM2023-3239","volume":"83","author":"S Fattori","year":"2023","unstructured":"Fattori, S. et al. Selective depletion of regulatory T cells by ALD2510, a novel IL-2-sparing anti-CD25 antibody, synergizes with PD-1 blockade in breast and gynecologic cancers. Cancer Res. 83, 3239 (2023).","journal-title":"Cancer Res."},{"key":"9721_CR16","doi-asserted-by":"crossref","unstructured":"Rech A. J. & Vonderheide R. H. Clinical use of anti-CD25 antibody daclizumab to enhance immune responses to tumor antigen vaccination by targeting regulatory T cells. in (eds Steinman R., Banchereau J., Finn O. J.) Cancer Vaccines (Blackwell, 2009).","DOI":"10.1111\/j.1749-6632.2009.04939.x"},{"key":"9721_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-148","volume":"11","author":"CR Tan","year":"2013","unstructured":"Tan, C. R. et al. Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model. J. Transl. Med. 11, 148 (2013).","journal-title":"J. Transl. Med."},{"key":"9721_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113191","volume":"28","author":"SQ Gu","year":"2025","unstructured":"Gu, S. Q. et al. Transient regulatory T cell manipulation is limited by anti-antibody responses in HIV-1 envelope immunized rhesus macaques. Iscience 28, 113191 (2025).","journal-title":"Iscience"},{"key":"9721_CR19","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/s41577-018-0046-y","volume":"18","author":"R Spolski","year":"2018","unstructured":"Spolski, R., Li, P. & Leonard, W. J. Biology and regulation of IL-2: from molecular mechanisms to human therapy. Nat. Rev. Immunol. 18, 648\u2013659 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"9721_CR20","doi-asserted-by":"publisher","first-page":"15424","DOI":"10.1021\/acsnano.3c00991","volume":"17","author":"FS Li","year":"2023","unstructured":"Li, F. S. et al. Periodic mesoporous organosilica as a nanoadjuvant for subunit vaccines elicits potent antigen-specific germinal center responses by activating naive B cells. Acs Nano 17, 15424\u201315440 (2023).","journal-title":"Acs Nano"},{"key":"9721_CR21","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s43018-020-00133-0","volume":"1","author":"I Solomon","year":"2020","unstructured":"Solomon, I. et al. CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity. Nat. Cancer 1, 1153\u2013115 (2020).","journal-title":"Nat. Cancer"},{"key":"9721_CR22","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.1073\/pnas.1820388116","volume":"116","author":"M Onda","year":"2019","unstructured":"Onda, M., Kobayashi, K. & Pastan, I. Depletion of regulatory T cells in tumors with an anti-CD25 immunotoxin induces CD8 T cell-mediated systemic antitumor immunity. Proc. Natl. Acad. Sci. USA 116, 4575\u20134582 (2019).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9721_CR23","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1146\/annurev-immunol-120419-022408","volume":"40","author":"GD Victora","year":"2022","unstructured":"Victora, G. D. & Nussenzweig, M. C. Germinal centers. Annu. Rev. Immunol. 40, 413\u2013442 (2022).","journal-title":"Annu. Rev. Immunol."},{"key":"9721_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/imr.12411","volume":"271","author":"PT Sage","year":"2016","unstructured":"Sage, P. T. & Sharpe, A. H. T follicular regulatory cells. Immunol. Rev. 271, 246\u2013259 (2016).","journal-title":"Immunol. Rev."},{"key":"9721_CR25","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1111\/imcb.12800","volume":"102","author":"TE Pankhurst","year":"2024","unstructured":"Pankhurst, T. E. & Linterman, M. A. Highlight of 2023: advances in germinal centers. Immunol. Cell Biol. 102, 463\u2013466 (2024).","journal-title":"Immunol. Cell Biol."},{"key":"9721_CR26","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41591-020-0753-3","volume":"26","author":"TJ Moyer","year":"2020","unstructured":"Moyer, T. J. et al. Engineered immunogen binding to alum adjuvant enhances humoral immunity. Nat. Med. 26, 430\u201343 (2020).","journal-title":"Nat. Med."},{"key":"9721_CR27","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.immuni.2015.04.005","volume":"42","author":"EC Rosser","year":"2015","unstructured":"Rosser, E. C. & Mauri, C. Regulatory B cells: origin, phenotype, and function. Immunity 42, 607\u2013612 (2015).","journal-title":"Immunity"},{"key":"9721_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1038\/s41577-022-00753-w","volume":"23","author":"BF Haynes","year":"2023","unstructured":"Haynes, B. F. et al. Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies. Nat. Rev. Immunol. 23, 142\u2013158 (2023).","journal-title":"Nat. Rev. Immunol."},{"key":"9721_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s11684-019-0721-9","volume":"14","author":"Q Wang","year":"2020","unstructured":"Wang, Q. & Zhang, L. Q. Broadly neutralizing antibodies and vaccine design against HIV-1 infection. Front. Med. 14, 30\u201342 (2020).","journal-title":"Front. Med."},{"key":"9721_CR30","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.ijid.2021.11.009","volume":"114","author":"CF Zheng","year":"2022","unstructured":"Zheng, C. F. et al. Real-world effectiveness of COVID-19 vaccines: a literature review and meta-analysis. Int. J. Infect. Dis. 114, 252\u2013260 (2022).","journal-title":"Int. J. Infect. Dis."},{"key":"9721_CR31","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.1016\/j.vaccine.2023.03.019","volume":"41","author":"T Kingsley","year":"2023","unstructured":"Kingsley, T., Phelan, D. & Poland, G. A. A review of 2023 adult immunization schedule updates. Vaccine 41, 2631\u20132633 (2023).","journal-title":"Vaccine"},{"key":"9721_CR32","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","volume":"27","author":"JL Excler","year":"2021","unstructured":"Excler, J. L., Saville, M., Berkley, S. & Kim, J. H. Vaccine development for emerging infectious diseases. Nat. Med. 27, 591\u2013600 (2021).","journal-title":"Nat. Med."},{"key":"9721_CR33","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.3389\/fimmu.2018.01963","volume":"9","author":"S Rauch","year":"2018","unstructured":"Rauch, S., Jasny, E., Schmidt, K. E. & Petsch, B. New vaccine technologies to combat outbreak situations. Front. Immunol. 9, 1963 (2018).","journal-title":"Front. Immunol."},{"key":"9721_CR34","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1056\/NEJMoa2208343","volume":"387","author":"S Chalkias","year":"2022","unstructured":"Chalkias, S. et al. A bivalent omicron-containing booster vaccine against Covid-19. N. Engl. J. Med. 387, 1279\u20131291 (2022).","journal-title":"N. Engl. J. Med."},{"key":"9721_CR35","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1080\/14760584.2023.2232851","volume":"22","author":"S Pather","year":"2023","unstructured":"Pather, S., Muik, A., Rizzi, R. & Mensa, F. Clinical development of variant-adapted BNT162b2 COVID-19 vaccines: the early Omicron era. Expert Rev. Vaccines 22, 650\u2013661 (2023).","journal-title":"Expert Rev. Vaccines"},{"key":"9721_CR36","doi-asserted-by":"crossref","unstructured":"Wang, L. M., Fu, Y. & Chu, Y. W. Regulatory B Cells. in (ed Wang J. Y.) B Cells in Immunity and Tolerance (Springer, 2020).","DOI":"10.1007\/978-981-15-3532-1_8"},{"key":"9721_CR37","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1038\/s41590-022-01347-3","volume":"23","author":"I Quast","year":"2022","unstructured":"Quast, I. & Tarlinton, D. Time is of the essence for vaccine success. Nat. Immunol. 23, 1517\u20131519 (2022).","journal-title":"Nat. Immunol."},{"key":"9721_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00875-3","volume":"9","author":"L Lotspeich-Cole","year":"2024","unstructured":"Lotspeich-Cole, L. et al. Sustained antigen delivery improves germinal center reaction and increases antibody responses in neonatal mice. Npj Vaccines 9, 92 (2024).","journal-title":"Npj Vaccines"},{"key":"9721_CR39","doi-asserted-by":"publisher","first-page":"E6639","DOI":"10.1073\/pnas.1606050113","volume":"113","author":"HH Tam","year":"2016","unstructured":"Tam, H. H. et al. Sustained antigen availability during germinal center initiation enhances antibody responses to vaccination. Proc. Natl. Acad. Sci. USA 113, E6639\u2013E6648 (2016).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"9721_CR40","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.3390\/vaccines10071103","volume":"10","author":"ZJ Sun","year":"2022","unstructured":"Sun, Z. J. et al. The role of cellular immunity in the protective efficacy of the SARS-CoV-2 vaccines. Vaccines 10, 1103 (2022).","journal-title":"Vaccines"},{"key":"9721_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s40364-024-00581-1","volume":"12","author":"M Zeng","year":"2024","unstructured":"Zeng, M., Zhang, W., Li, Y. S. & Yu, L. Harnessing adenovirus in cancer immunotherapy: evoking cellular immunity and targeting delivery in cell-specific manner. Biomark. Res. 12, 36 (2024).","journal-title":"Biomark. Res."},{"key":"9721_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.938598","volume":"13","author":"LJ Bian","year":"2022","unstructured":"Bian, L. J. et al. Intramuscular inoculation of AS02-adjuvanted respiratory syncytial virus (RSV) F subunit vaccine shows better efficiency and safety than subcutaneous inoculation in BALB\/c mice. Front. Immunol. 13, 938598 (2022).","journal-title":"Front. Immunol."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09721-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09721-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09721-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:48:38Z","timestamp":1774536518000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-09721-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,17]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9721"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-09721-9","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,17]]},"assertion":[{"value":"24 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"447"}}